To highlight the critical role of hypothesis-driven thalamic SEEG in optimizing neuromodulation strategies for drug-resistant epilepsy, emphasizing its potential to improve patient outcomes.
Key Findings:
RNS shows a median 58% seizure reduction after 3 years, improving to 75% after 9 years, indicating long-term efficacy.
Thalamic neuromodulation strategies have emerged for unilateral and bilateral seizure networks, suggesting a broader application of these techniques.
Bilateral CM-region RNS achieved a median seizure reduction of 81% at 1 year, demonstrating its effectiveness in specific patient populations.
Interpretation:
The thalamus plays a crucial role in seizure networks, and understanding its specific involvement can enhance treatment outcomes for patients with drug-resistant epilepsy, guiding clinical decision-making.
Limitations:
Under-utilization of epilepsy surgery remains a public health crisis, with significant implications for patient care.
Real-world effectiveness of ANT-DBS varies significantly among patients, highlighting the need for personalized treatment approaches.
Conclusion:
Hypothesis-driven thalamic SEEG is essential for identifying optimal neuromodulation targets, which can lead to improved treatment outcomes for patients with drug-resistant epilepsy, ultimately enhancing their quality of life.
